87745-18-4[2H]C([2H])([2H])CCC(CCC([2H])([2H])[2H])C(=O)ONIJJYAXOARWZEE-WFGJKAKNSA-N87745-18-4DTXSID00236605Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
UsesAntiepileptic; increases levels of -aminobutyric acid(GABA) in the brain. Anticonvulsant that also has efficacy as a mood stabilizer in bipolar disorder.
General DescriptionAn internal standard and Certified Spiking Solution suitable for quantitation of valproic acid levels in urine or other matrices by LC/MS or GC/MS for testing applications in clinical toxicology, forensic analysis, medication monitoring, urine drug testing, or therapeutic drug monitoring. Valproic acid, sold under trade names such as Depakote, Valparin, or Stavzor, is an antiepileptic drug and mood stabilizer. The drug is prescribed for treatment of epilepsy, bipolar disorder, migraine headaches, and depression.
Loading…
Loading…
No reaction records under the current filter.
Loading…